Todd Inman's most recent trade in OptimizeRx Corp was a trade of 771 Restricted Stock Units done . Disclosure was reported to the exchange on March 1, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| OptimizeRx Corp | Todd Inman | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 771 | 1,542 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Todd Inman | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 771 | 771 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Todd Inman | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.11 per share. | 01 Mar 2023 | 233 | 538 (0%) | 0% | 18.1 | 4,220 | Common Stock |
| OptimizeRx Corp | Todd Inman | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 19,527 | 19,527 | - | - | Stock Option | |
| OptimizeRx Corp | Todd Inman | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 9,973 | 9,973 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Todd Inman | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 4,690 | 4,690 | - | - | Stock Option | |
| OptimizeRx Corp | Todd Inman | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 2,313 | 2,313 | - | - | Restricted Stock Units |